Janita Good looks at some of the therapeutics currently under investigation and the issues they have highlighted in the context of a pandemic.
Janita Good
Advertisement
Janita Good is Head of UK Life Sciences at Fieldfisher.
Articles by Janita Good
Advertisement
Latest Updated Articles
COVID-19: Therapeutics Under InvestigationPublished: March 31st 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
